Psychological Status and Related Factors of Thyroid Related Eye Disease
2020年5月21日 更新者:Huijing Ye
The purpose of this study is to evaluate the psychological status of Thyroid Related Eye Disease.
研究概览
详细说明
The purpose of this study is to evaluate the psychological status of patients of Thyroid Related Eye Disease over 16 years old, and to analyze the related factors of them.
研究类型
观察性的
注册 (实际的)
300
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Guangdong
-
Guangzhou、Guangdong、中国、510000
- Sun Yat-sen University
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
16年 及以上 (孩子、成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
取样方法
概率样本
研究人群
patients in Sun Yat-sen University that diagnosed as Thyroid Related Eye Disease
描述
Inclusion Criteria:
- over 16 years old
- diagnosed as Thyroid Related Eye Disease
Exclusion Criteria:
- any uncontrolled clinical problems
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
---|---|
Thyroid Related Eye Disease
Survey about the psychological condition would done with the patients of Thyroid Related Eye Disease
|
Graves ́ ophthalmopathy quality of life questionnaire, Symptom checklist 90(SLC-90), Hamilton anxiety scale(HAMA), Somatic self-rating scale(SSS), MATRICS Consensus Cognitive Battery (MCCB), Hamilton depression scale(HAMD)
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Quality of life questionnaire of patients of Thyroid Related Eye Disease
大体时间:immediately
|
Graves ́ ophthalmopathy quality of life questionnaire (GO-QoL) , The GO-QoL contains 8 questions on visual functioning and 8 questions on appearance; answers on each subscale are transformed to scores ranging from 0 (worst) to 100 (best).
|
immediately
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Symptom checklist 90(SLC-90)
大体时间:immediately
|
It consists of 90 items yielding nine scores along primary symptom dimensions and three scores among global distress indices.
The primary symptom dimensions that are assessed are somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of "additional items" which helps clinicians assess other aspect of the clients symptoms.
Positive standard includes: total score 160 points or more, or positive items > 43 points, or any item > 2 points.
|
immediately
|
Hamilton anxiety scale(HAMA)
大体时间:immediately
|
This scale includes 14 items.
All projects rated as: asymptomatic, light, medium, heavy, or very heavy.
If the total score more than 29 points, there could be severe anxiety; more than 21 points, affirmation have obvious anxiety; more than 14 points, there must be some anxious; more than 7 points might be anxious; if less than 6 points, patients without anxiety symptoms.
|
immediately
|
Somatic self-rating scale(SSS)
大体时间:immediately
|
Somatic self-rating scale can let the doctor fully understand patients' mood and somatization symptoms.
If the selected items scores more than 30 points, the patient may need to clinic treatment.
|
immediately
|
Hamilton depression scale(HAMD)
大体时间:immediately
|
It is the most common depression clinical application scale.
Lower score presents lighter condition, and if the illness is heavier, the higher is the score.
There is no depression symptoms for score less than eight points.
|
immediately
|
Young manic rating scale(YMRS)
大体时间:immediately
|
The Young Mania Rating Scale (YMRS) is a diagnostic questionnaire commonly used to evaluate manic symptoms in patients with bipolar 1 disorder and to assess treatment efficacy in clinical trials.
This rating scale comprises eleven items (elevated mood, increased motor activity - energy, sexual interest, sleep, irritability, speech - rate and amount, language-thought disorder, content, disruptive-aggressive behavior, appearance, and insight).
The total YMRS score is calculated as the summation of each of the eleven individual item scores.Lower score presents lighter condition, and if the illness is heavier, the higher is the score.There is no manic symptoms for score less than five points.
|
immediately
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
赞助
调查人员
- 首席研究员:Huijing Ye, Master、Sun Yat-sen University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2017年12月1日
初级完成 (实际的)
2018年12月1日
研究完成 (实际的)
2018年12月31日
研究注册日期
首次提交
2018年2月1日
首先提交符合 QC 标准的
2018年2月7日
首次发布 (实际的)
2018年2月8日
研究记录更新
最后更新发布 (实际的)
2020年5月21日
上次提交的符合 QC 标准的更新
2020年5月21日
最后验证
2020年5月1日
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
未定
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
psychological condition的临床试验
-
University of California, San FranciscoUnited States Department of Defense; San Francisco Veterans Affairs Medical Center完全的